🇺🇸 FDA
Patent

US 10688063

Treating and/or preventing insulin-resistance related weight gain

granted A61KA61K31/122A61K31/341

Quick answer

US patent 10688063 (Treating and/or preventing insulin-resistance related weight gain) held by The United States Government as Represented by the Department of Veterans Affairs of General Counsel- PSG IV (024) expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government as Represented by the Department of Veterans Affairs of General Counsel- PSG IV (024)
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/122, A61K31/341, A61P, A61P3/04